The impact of renin-angiotensin system polymorphisms on physiological and pathophysiological processes in humans

Current Opinion in Nephrology and Hypertension

Volumn 13, Issue 1, 2004, Pages 101-106

  Miller, Judith A ^a,b   Scholey, James W ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Angiotensin 1 A1166C polymorphism; Angiotensin converting enzyme insertion deletion polymorphism; Angiotensinogen M235T polymorphism; Diabetes mellitus; Essential hypertension; Physiology; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

DIABETES MELLITUS; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; ENZYME POLYMORPHISM; GENOTYPE PHENOTYPE CORRELATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RACE DIFFERENCE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SEX DIFFERENCE; SODIUM BLOOD LEVEL;

ANGIOTENSINOGEN; ANIMALS; GENE DELETION; HUMANS; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM;

EID: 4043126826     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200401000-00014     Document Type: Review

References (42)

1. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiolensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-1346.
2. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin coverting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359:641-644.
3. Staessen JA, Wang JG, Ginocchio G, et al. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997; 15:1579-1592.
4. Keavney B, McKenzie C, Parish S, et al. Large-scale test of hypothesized associations between the angiotensin converting enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators. Lancet 2000; 355:434-442.
5. Van Der Kleij FGH, De Jong PE, Henning RH, et al. Enhanced responses of blood pressure, renal function, and aldosterone to angiotensin I in the DD genotype are blunted by low sodium intake. J Am Soc Nephrol 2002; 13:1025-1033. This elegant study demonstrates the physiological impact of the ACE I/D polymorphism by showing that the response to angiotensin I is enhanced in individuals with the DD genotype, and that furthermore, this can be blunted by sodium depletion.
6. Henskens LH, Spiering W, Stoffers HE, et al. Effects of ACE I/D and AT1R-A1166C polymorphisms on blood pressure in a healthy normotensive primary care population: first results of the Hippocrates study. J Hypertens 2003; 21:81-86.
7. Iliadou A, Lichtenstein P, Morgenstern R, et al. Repeated blood pressure measurements in a sample of Swedish twins: heritabilities and associations with polymorphisms in the renin-angiotensin-aldosterone system. J Hypertens 2002; 20:1543-1550.
8. Mello G, Parretti E, Gensini F, et al. Maternal-fetal flow, negative events, and pre-eclampsia: role of ACE I/D polymorphism. Hypertension 2003; 41:932-937.
9. Miller JA, Scholey JW, Thai K, Pei YPC. Angiotensin converting enzyme gene polymorphism and renal hemodynamic dysfunction in early diabetes. Kidney Int 1997; 51:119-124.
10. Luik PT, Hoogenberg K, Kerstens MN, et al. The influence of the ACE (I/D) polymorphism on the systemic and renal vascular responses to angiotensins in normotensive, normoalbuminuric type 1 diabetes mellitus. Diabetologia 2003; 46:1131-1139. This study shows that the ACE I/D genotype has an impact in a group of diabetic patients, in that the angiotensin I response is enhanced in the DD genotype subgroup, and furthermore that this relationship can be affected by sodium intake and glucose control.
11. Kostis JB, Wilson AC, Hooper WC, et al. Association of angiotensin-converting enzyme DD genotype with blood pressure sensitivity to weight loss. Am Heart J 2002; 144:625-629.
12. Schwartz GL, Turner ST, Chapman AB, Boerwinkle E. Interacting effects of gender and genotype on blood pressure response to hydrochlorothiazide. Kidney Int 2002; 62:1718-1723.
13. Sciarrone MT, Stella P, Barlassina C, et al. ACE and α-adducin polymorphism as markers of individual response to diuretic therapy. Hypertension 2003; 41:398-403.
14. Bonnardeaux A, Davies E, Jeunemaitre X, et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994; 24:63-69.
15. Buraczynska M, Ksiazek P, Zaluska W, et al. Angiotensin II type 1 receptor gene polymorphism in end-stage renal disease. Nephron 2002; 92:51-55.
16. Reich H, Duncan JA, Weinstein J, et al. Interactions between gender and the angiotensin type 1 receptor gene polymorphism. Kidney Int 2003; 63:1443-1449. A physiological study that demonstrates the impact of sex and genotype on the relationship between the A1166C polymorphism and blood pressure, and the A1166 genotype and the response to angiotensin II.
17. Mettimano M, Romano-Spica V, Ianni A, et al. AGT and AT1R gene polymorphism in hypertensive heart disease. Int J Clin Pract 2002; 56:574-577.
18. Fradin S, Goulet-Salmon B, Chantepie M, et al. Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients. Diabet Metab 2002; 28:27-32.
19. Barbeau P, Kulharya A, Harshfield G, et al. Association between angiotensin II type 1 receptor polymorphism and resting hemodynamics in black and white youth. Ethnic Dis 2002; 12 (Suppl. 1):68-71.
20. Hindorff LA, Heckbert SR, Tracy R, et al. Angiotensin II type 1 receptor polymorphisms in the cardiovascular health study: relation to blood pressure, ethnicity, and cardiovascular events. Am J Health 2002; 15:1050-1056.
21. Miller JA, Thai K, Scholey JW. Angiotensin II type 1 receptor genepolymorphism predicts renal responses to losartan and angiotensin II. Kidney Int 1999; 56:2173-2180.
22. Miller JA, Anacta LA, Cattran DC. Impact of gender on the renal response to angiotensin II. Kidney Int 1999; 55:278-285.
23. Gaillard-Sanchez I, Mattei MG, Clause E, Corvol P. Assignment of the angiotensinogen gene to chromosome band 1q4, the same region as the human renin gene. Hum Genet 1990; 84:341-343.
24. Isa MN, Boyd E, Morrison N, et al. Assignment of the human angiotensin gene to chromosome 1q42-q43 by nonisotopic in situ hybridisation. Genomics 1990; 8:598-600.
25. Gaillard I, Clauser E, Corvol P. Structure of the angiotensinogen gene. DNA 1989; 8:87-99.
26. Ohkubo H, Kageyama R, Ujihara M, et al. Cloning and sequence analysis of cDNA for rat angiotensinogen. Proc Natl Acad Sci U S A 1983; 80:2196-2200.
27. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71:7-20.
28. Hata A, Namikawa C, Saski M, et al. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994; 93:1285-1287.
29. Inoue I, Nakajima T, Williams CS, et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997; 99:1786-1797.
30. Caulfield M, Lavender P, Newell-Price J, et al. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest 1995; 96:687-692.
31. Caulfield M, Lavender P, Farrall M, et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994; 330:1629-1633.
32. Hegele RA, Brunt JH, Connelly PW. A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. Circulation 1994; 90:2207-2212.
33. Niu T, Xu X, Rogus J, et al. Angiotensinogen gene and hypertension in Chinese. J Clin Invest 1998; 101:188-194.
34. Periera AC, Mota GFA, Cunha RS, et al. Angiotensinogen 235T allele dosage is associated with blood pressure phenotypes. Hypertension 2003; 41:25-30. The finding suggestive of a gene dose effect for the T235 allele in this population is similar to observations in angiotensinogen transgenic mice.
35. Sethi AA, Nordestgaard BG, Gronholdt MM, et al. Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease. Hypertension 2003; 41:1202-1211.
36. Tiago AD, Samani NJ, Candy GP, et al. Angiotensinogen gene promoter region variant modifies body size-ambulatory blood pressure relations in hypertension. Circulation 2002; 106:1483-1487. The authors studied a number of angiotensinogen gene polymorphisms, but the findings focus on the functional polymorphism in the angiotensinogen gene promoter.
37. Zhu X, Chang YPC, Yan D, et al. Associations between hypertension and genes in the renin angiotensin system. Hypertension 2003; 41:1027-1034.
38. Hopkins PN, Liffon RP, Hollenberg NK. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens 1996; 14:199-207.
39. Hopkins PN, Hunt SC, Jeunemaitre X, et al. Angiotensinogen genotype affects renal and adrenal responses to angiotensin II in essential hypertension. Circulation 2002; 105:1921-1927. This ambitious study examines sex and ethnic interactions with the angiotensinogen genotype on hemodynamic responses, and utilizes the functional promotor polymorphism.
40. Krizanova O, Koska J, Vigas M, Kvetnansky R. Correlation of M235T DNA polymorphism with cardiovascular and endocrine responses during physical exercise in healthy subjects. Physiol Res 1998; 47:81-88.
41. Rankinen T, Gagnon J, Perusse L, et al. AGT M235T and ACE ID polymorphisms and exercise blood pressure in the HERITAGE Family Study. Am J Physiol 2000; 279:H368-H374.
42. McCole SD, Brown MD, Moore GE, et al. Angiotensinogen M235T polymorphism associates with exercise hemodynamics in postmenopausal women. Physiol Genomics 2002; 10:63-69. This study focuses on cardiovascular regulation during exercise, and the results suggest that there may be mechanistic links between exercise-induced changes in cardiovascular function and hypertension.